Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec. 173 of the Companies Act, 2013, SMS Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on the Monday, 12th day of August, 2019, at the Registered Office of the Company, to consider and approve the Un-audited Financial results of the Company for the First Quarter ended 30th June, 2019. Further, Insider Trading window of the company shall remain closed till 14th August, 2019 in view of the above mentioned Board Meeting.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 594.45 |
Dr. Reddys Lab | 5078.65 |
Lupin | 1087.45 |
Piramal Enterprises | 1596.40 |
Cadila Healthcare | 485.95 |
View more.. |